Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Sergio Espinosa Gil

Sergio Espinosa Gil

Institutions of which they are part

Postdoctoral researcher
Protein kinases in cancer research
Vall Hebron Institut de Recerca
Sergio Espinosa Gil

Sergio Espinosa Gil

Sergio Espinosa Gil

Institutions of which they are part

Postdoctoral researcher
Protein kinases in cancer research
Vall Hebron Institut de Recerca

Projects

Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders

IP: Lucas Moreno Martín-Retortillo
Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Maria Jose Pérez García, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Raquel Hladun Alvaro, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Gabriela Guillén Burrieza, Laura Alonso Garcia, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Claire Diot, Amira Idrizovic
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00638
Duration: 01/01/2022 - 30/06/2025

Related news

Dr. Sergio Espinosa i Dr. José M Lizcano

A study sheds light on the mechanism through which metabolites guide cellular decisions

The report, published in Nature, reveals that polyamines bind to specific domains in proteins and operate as a metabolic shield against modifications in their structure.

Laboratori de Sarcomes Infantils

VHIR drives cancer research with new personalized therapies and advances in biomarkers

On World Cancer Research Day, we highlight research aimed at improving treatments for both pediatric and adult cancers through innovative techniques.

Laboratori de Sarcomes Infantils

New therapeutic target for an aggressive childhood cancer affecting the muscles

The research team has shown that inhibiting the TRIB3 protein slows the growth of rhabdomyosarcoma and improves survival in animal models.

See more

Related professionals

Sara Garcia Ortega

Sara Garcia Ortega

Predoctoral researcher
Translational Molecular Pathology
Read more
Paula Isabel Roldan Caballero

Paula Isabel Roldan Caballero

Clinical Research Development Directorate
Read more
Martina Garriga Ferrer

Martina Garriga Ferrer

Internal Strategy Directorate
Read more
Beatriz Soria Navarro

Beatriz Soria Navarro

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.